Print

HVTN 070

A Phase I clinical trial to evaluate the safety and immunogenicity of PENNVAX-B (gag, pol, env) with IL-12 or IL-15 DNA plasmid adjuvants, in healthy, HIV-1 uninfected adult participants

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN), University of Pennsylvania, Wyeth October 23, 2007
PENNVAX-B Env, gag, pol B
PENNVAX-B DNA
IL-12 DNA adjuvant
USA 120
NCT00528489
http://clinicaltrials.gov/ct2/results?term=PennVax